Results 231 to 240 of about 2,609,725 (348)

Development of a Novel Extracellular Vesicle-Based Biomarker Approach for Pediatric High-Grade Glioma. [PDF]

J Extracell Biol
Fernandez Garcia A, Iyer P, Ashi P, Tella I, Sangaraboina V, Bhagat D, Janarthanam C, Bargues-Carot A, Kanthasamy AG, Spoerer T, Golan ME, Stice SL, Funato K.   +12 more
europepmc   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

Molecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen, Kristiane Søreng, Chiara Veroni, Laura Trachsel‐Moncho, Nagham Asp, Robin Gaupset, Lars Gustav Lyckander, Helene Knævelsrud, Lars Eftang, Anne Simonsen   +9 more
wiley   +1 more source

Bioinspired Collective Synthesis of Gymnothelignans I, F, K, and L. [PDF]

J Org Chem
Chumsri N, Chualong K, Chairoungdua A, Kuhakarn C, Leowanawat P, Reutrakul V, Soorukram D.   +6 more
europepmc   +1 more source

Synthesis of Prodelphinidin Trimer Isolated from Cistus Albidus and its Growth Inhibitory Activity Against Human Prostate Cancer Cell Lines

, 2016
Hidefumi Makabe, Hiroshi Fujii, Masataka Mori, Kiriko Matsumoto, Chisato Ishihara, Koichiro Kawaguchi, Seiichi Kawahara, Yasunao Hattori   +7 more
openalex   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Pluripotent stem cell-derived extracellular vesicles: Cell type-dependent effect on tumorigenicity in cancer cell lines. [PDF]

J Cell Commun Signal
Du C, Narayanan K, Ganapathy A, Wan ACA.
europepmc   +1 more source

EFFECT OF A NEW ALKALOID ISOLATED FROM HYBRID BUTTERBUR ON CELL MOTILITY OF IMMORTALIZED COLORECTAL CANCER CELL LINES [PDF]

S.Y. Filippova, Татьяна Владимировна Чембарова, E.Yu. Zlatnik, I.V. Mezhevova, N.V. Gnennaya, I. N. Mironenko, I.A. Novikova, С. В. Тимофеева, Е. А. Дженкова, А. С. Гончарова, Олег Н. Буров   +10 more
openalex   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Characterization and Genetic Evolution of H6N2 Subtype AIV Isolates from Aquatic Birds. [PDF]

Microorganisms
Deng L, Shah T, Wang Y, Cheng P, Kui Y, Wang B, Xia X.   +6 more
europepmc   +1 more source

Production and characterisation of exopolysaccharide from Streptomyces carpaticus isolated from marine sediments in Egypt and its effect on breast and colon cell lines

, 2017
Manal S. Selim, Shaimaa K. Amer, Sahar S. Mohamed, Marwa M. Mounier, Hala M. Rifaat   +4 more
openalex   +1 more source